Abstract:Acute myeloid leukemia (AML) accounts for greater than twenty thousand new cases of leukemia annually in the United States. The average five-year survival rate is approximately 30%, pointing to the need for developing novel model systems for drug discovery. In particular, patients with chromosomal rearrangements in the mixed lineage leukemia (MLL) gene have higher relapse rates with poor outcomes. In this study we investigated the expression of human MLL-ENL and MLL-AF9 in the myeloid lineage of zebrafish embryos. We observed an expansion of MLL positive cells and determined these cells colocalized with the myeloid markers spi1b , mpx , and mpeg . In addition, expression of MLL-ENL and MLL-AF9 induced the expression of endogenous bcl2 and cdk9 , genes that are often dysregulated in MLL-r-AML. Co-treatment of lyz : MLL-ENL or lyz : MLL-AF9 expressing embryos with the BCL2 inhibitor, Venetoclax, and the CDK9 inhibitor, Flavopiridol, significantly reduced the number of MLL positive cells compared to embryos treated with vehicle or either drug alone. In addition, cotreatment with Venetoclax and Flavopiridol significantly reduced the expression of endogenous mcl1a compared to vehicle, consist with AML. This new model of MLL-r-AML provides a novel tool to understand the molecular mechanisms underlying disease progression and a platform for drug discovery. Acute myeloid leukemia (AML) accounts for over twenty thousand new cases of leukemia per year in the United States. MLL rearrangements (MLL-r) occur in approximately 10% of AML patients, with 34% of those harboring an MLL-ENL or MLL-AF9 rearrangement. Patients with an MLL-r have a higher relapse rate and their overall survival is low, pointing to a need for novel therapeutic interventions. Zebrafish have emerged as a powerful model system to study hematological malignancies due their conserved hematopoietic program, genetic tractability, and pharmacological accessibility. Expression of human MLL-ENL and MLL-AF9 in the myeloid lineage of zebrafish embryos induced an expansion of myeloid cells and caused an increase in expression of endogenous bcl2 and cdk9 . MLL expression was significantly reduced in lyz : MLL-ENL and lyz-MLL-AF9 embryos co-treated with the BCL2 inhibitor (Venetoclax) and the CDK9 inhibitor (Flavopiridol) compared to embryos treated with vehicle or either drug alone. Reduced MLL expression occurred in conjunction with a significant decrease in mcl1a expression, consistent with human AML cells. Taken together, these results further support the use of zebrafish to model hematological malignancies for drug discovery.

Establishment of a congenital amegakaryocytic thrombocytopenia model and a thrombocyte–specific reporter line in zebrafish

C-Myb Hyperactivity Leads to Myeloid and Lymphoid Malignancies in Zebrafish

Different mutations of the human c-mpl gene indicate distinct haematopoietic diseases

The Defective Expression of Gtpbp3 Related to Trna Modification Alters the Mitochondrial Function and Development of Zebrafish

A Point Mutation of Zebrafish C-Cbl Gene in the Ring Finger Domain Produces a Phenotype Mimicking Human Myeloproliferative Disease

Generation of a Thrombopoietin‐deficient Thrombocytopenia Model in Zebrafish

Human BCR/ABL1 Induces Chronic Myeloid Leukemia-Like Disease in Zebrafish

The establishment of AML1-EVI1 transgenic zebrafish model and regulation of hematopoietic transcription factors

Functions of Flt3 in Zebrafish Hematopoiesis and Its Relevance to Human Acute Myeloid Leukemia.

Human MLL-AF9 Overexpression Induces Aberrant Hematopoietic Expansion in Zebrafish

Mycn Transgenic Zebrafish Model With The Characterization Of Acute Myeloid Leukemia And Altered Hematopoiesis

Myeloid Targeted Human MLL-ENL and MLL-AF9 Induces cdk9 and bcl2 Expression in Zebrafish Embryos

Transgenic IDH2R172K and IDH2R140Q zebrafish models recapitulated features of human acute myeloid leukemia

Characterization of a novel zebrafish model of -associated CMT4B3

Generation and Characterization of Blood Vessel Specific EGFP Transgenic Zebrafish via To12 Transposon Mediated Enhancer Trap Screen

Microarray Analysis of Zebrafish Cloche Mutant Using Amplified Cdna and Identification of Potential Downstream Target Genes

Zebrafish as a Model for the Study of Human Myeloid Malignancies

The Influence of MYCN Gene on Hematopoietic Regulatory Factors in MYCN Transgenic Zebrafish

Zebrafish Cdc6 Hypomorphic Mutation Causes Meier-Gorlin Syndrome-Like Phenotype

Establishment of Zebrafish Model Via TIE2-R849W and Exploration of Its Role in Hereditary Venous Malformations

Differential in vivo roles of Mpl cytoplasmic tyrosine residues in murine hematopoiesis and myeloproliferative disease